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ABSTRACT
Epigenetic regulation of gene expression is import-
ant in maintaining self-renewal of embryonic stem
(ES) and trophoblast stem (TS) cells. Histone
deacetylases (HDACs) negatively control histone
acetylation by removing covalent acetylation
marks from histone tails. Because histone acetyl-
ation is a known mark for active transcription,
HDACs presumably associate with inactive genes.
Here, we used genome-wide chromatin immunopre-
cipitation to investigate targets of HDAC1 in ES and
TS cells. Through evaluation of genes associated
with acetylated histone H3 marks, and global
expression analysis of Hdac1 knockout ES and
trichostatin A-treated ES and TS cells, we found
that HDAC1 occupies mainly active genes, including
important regulators of ES and TS cells self-
renewal. We also observed occupancy of methyl-
CpG binding domain protein 3 (MBD3), a subunit of
the nucleosome remodeling and histone
deacetylation (NuRD) complex, at a subset of
HDAC1-occupied sequences in ES cells, including
the pluripotency regulators Oct4, Nanog and Kfl4.
By mapping HDAC1 targets on a global scale, our
results describe further insight into epigenetic
mechanisms of ES and TS cells self-renewal.
INTRODUCTION
Eukaryotic organisms solve the immense challenge of
packaging 2m of DNA into the nucleus of each cell in
a conformation that is conducive for transcriptional
regulation by compacting DNA into chromatin.
Nucleosomes, which are the core unit of chromatin,
consist of DNA wrapped around an octamer of
histones. Post-translational modiﬁcations of histone
tails, such as acetylation, play critical roles in regulating
transcription and chromatin structure. The expression
state of a gene is largely correlated with its histone acetyl-
ation state. Histone deacetylases (HDACs), which nega-
tively control histone acetylation by removing acetyl
groups from histone tails, are generally thought to be tran-
scriptional repressors. HDACs have been found to act as
co-repressors in complexes such as the nucleosome re-
modeling and histone deacetylation (NuRD), SIN3
complexes and CoREST (1,2). HDAC1 is also required
for embryo development (3), where HDAC1 null
embryos die before E10.5, and HDACs have been
shown to play an important role in embryonic stem (ES)
cell differentiation (3). While HDAC1-deﬁcient ES cells
exhibit abnormal differentiation (4), a loss of either
HDAC1 (4,5) or HDAC2 (5) does not seem to affect ES
cell proliferation. In mouse genetic studies, deletion of
both HDAC1 and HDAC2 is required to produce a
phenotype in a tissue-speciﬁc manner, suggesting that
the activities of HDAC1 and HDAC2 are largely redun-
dant (6,7). HDAC inhibitors such as trichostatin A (TSA)
have been used to address the overarching roles of Classes
I and II HDACs in ES cell function, where treatment of
ES cells with TSA inhibits differentiation (8). HDAC in-
hibitors also aid in the reprogramming process, where
TSA treatment of cloned embryos improves heterochro-
matin remodeling (9), and TSA, valproic acid (VPA) and
suberoylanilide hydroxamic acid (SAHA) signiﬁcantly
improve the efﬁciency of generating induced pluripotent
stem (iPS) cells (10). Recent evidence also demonstrates
that HDACs are located at active and inactive genes (11).
HDACs were found to bind more active than inactive
genes, suggesting that HDACs may function in
removing acetyl groups added by histone acetyl transfer-
ases during transcriptional initiation and elongation to
assist in transcriptional elongation and prevent indiscrim-
inate initiation (11).
To further understand epigenetic phenomena that con-
tribute to chromatin structure and regulate gene expres-
sion, we evaluated promoter occupancy of HDAC1 in ES
and trophoblast stem (TS) cells using genome-wide
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analysis (ChIP-chip). By evaluating genes marked with
acetylated histone H3 (AcH3), and transcriptome
analysis of Hdac1 knockout ES cells and ES and TS
cells treated with TSA, we observed HDAC1 binding to
active and inactive genes in ES and TS cells. Surprisingly,
we observed HDAC1 binding to predominantly active
genes in ES and TS cells, including genes whose expression
is enriched in ES cells such as the core
pluripotency-related factors Oct4, Sox2 and Nanog and
genes whose expression is enriched in TS cells such as
Cdx2, Elf5, Eomes and Sox2. We also identiﬁed a fewer
number of inactive genes bound by HDAC1, without
AcH3 marks, suggesting that HDAC1 binds a reduced
number of inactive genes. In addition, we evaluated
global promoter occupancy of MBD3, a component of
the NuRD complex, in ES cells. Our results show that
MBD3 co-binds a subset of HDAC1 targets in ES cells,
including the pluripotency regulators Oct4, Nanog and
Klf4. Overall, our results demonstrate that HDAC1
occupies critical genes involved in maintaining
self-renewal of ES and TS cells.
MATERIALS AND METHODS
ES cell culture
R1 ES cells, obtained from ATCC (Manassas, VA, USA),
were cultured as previously described (12). Brieﬂy, R1 ES
cells were cultured on gelatin-coated dishes without feeder
cells in serum-free media containing LIF and BMP4
(ESGRO Complete Clonal Grade Medium, Chemicon)
at 37C with 5% CO2. ES cells were passed by washing
with PBS, and dissociating with Accutase (Millipore). For
TSA treatment, ES cells were transitioned to feeder-free
conditions and cultured for 24h with 0, 10, 50 or 100nM
TSA (Sigma).
TS cell culture
TS cells were cultured as previously described (13). TS
cells (TSC-BK12) were cultured in dishes containing
g-irradiated MEFs and RPMI 1640 medium supple-
mented with 20% FBS (Gibco), 1mM sodium pyruvate
(Gibco), 100mM b-mercaptoethanol (Chemicon), 2mM
L-glutamine (Gibco), 25ng/ml recombinant human
FGF4 (1) (R&D Systems) and 1mg/ml heparin (1)
(Sigma). For ChIP-chip experiments, TS cells were
passed twice to remove feeder cells in TS cell media con-
taining 70% iMEF-conditioned medium, 1.5 X FGF4 and
heparin at 37C with 5% CO2.
qRT–PCR expression analysis
RNA isolation and qRT–PCR were performed as previ-
ously described with minor modiﬁcations (12). ES cells
were harvested using Accutase to dissociate cells. Total
RNA was harvested from ES cells using an RNeasy
Mini Kit (Qiagen, Valencia, CA, USA) and DNase
treated using Turbo DNA-free (Ambion) for 30min at
37C. Reverse transcription was performed using 1mg
total RNA and a SuperScript III kit with random
hexamer primers (Invitrogen, Carlsbad, CA, USA).
qPCR was performed using TaqMan probes and
TaqMan Universal PCR Master Mix reagents (Applied
Biosystems), or non-labeled primers and SYBR Green
PCR Master Mix reagents (Applied Biosystems). Primers
used for qPCR with SYBR green reagents were designed
using Primer3 (http://frodo.wi.mit.edu/).
ChIP-chip analysis
ChIP-chip and ChIP-PCR experiments were performed as
previously described with minor modiﬁcations (12,13).
The polyclonal HDAC1 (ab7028) and MBD3 antibodies
were obtained from Abcam. Brieﬂy, 110
8 mouse ES
(R1) and TS cells (TSC-BK12), all feeder-free were har-
vested and chemically cross-linked with 1% formaldehyde
(Sigma) and subsequently sonicated. Sonicated cell
extracts equivalent to 210
6 cells were used for
immunoprecipitation assays. Five micrograms ampliﬁed
ChIP-enriched DNA (ES cell HDAC1-ChIP, ES cell
MBD3-ChIP, TS cell HDAC1-ChIP and corresponding
Input whole-cell extracts for ES and TS cells) were
DNase treated, labeled and hybridized to Affymetrix
mouse promoter 1.0R tiling arrays. Mouse promoter
1.0R DNA tiling arrays contain 4.6 million 25-mer oligo-
nucleotide probes spanning a distance of 6 to +2.5kb
relative to the transcriptional start site (TSS) for 28000
mouse promoter regions, providing a resolution of 35bp
with 10-bp gaps between probes. At least three biological
replicates were used for each ChIP-chip analysis. Quantile
normalization, including probe intensity computation and
log2 adjustment, was applied to the tiling array data using
CisGenome (14). Peak detection and gene annotation were
performed as previously described (12,13,15). Brieﬂy, peak
detection was performed using the TileMap (16) applica-
tion in CisGenome (14). MA statistics was applied to
analyze the tiling array data. Post-ﬁltering included dis-
carding peaks if the total length was <100bp, or if there
were less than three continuous probes passing the cut-off,
and merging two adjacent peaks if the gap between the
two peaks was <300bp and if there were less than ﬁve
probes that did not pass the cut-off between the two
peaks. Peaks with an FDR <0.10 were also discarded.
Enrichment peaks were annotated with the closest gene
using build 36 of the mouse genome.
Clustering analysis of promoter binding data
Promoter-binding patterns for HDAC1 were centered on
enrichment peaks [2kb, +2kb] and visualized by hier-
archical clustering analysis (HCA). Promoter regions
where >25% of probes were absent were not included in
this analysis. Hierarchical clustering was performed using
Spotﬁre software.
Global expression analysis of TSA-treated ES and
TS cells
Total RNA was isolated from the ES and TS cells cultured
in the presence of 0, 10, 50 or 100nM TSA for 24h
using an RNeasy Mini Kit (Qiagen, Valencia, CA,
USA). For each duplicate biological replicate, 100ng of
RNA was ampliﬁed using a MessageAmp Premier RNA
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aRNA was hybridized to Affymetrix mouse 430 v2.0
microarrays. Analysis was performed as previously
described with minor modiﬁcations (13). Brieﬂy, CEL
ﬁles were loaded into ArrayAssist (Stratagene, La Jolla,
CA, USA) and probes were normalized using the
GC-RMA algorithm. Analysis of variance (ANOVA)
was performed on all groups using a Benjamini and
Hochberg FDR correction. Genes whose expression
differed by at least 2-fold between any two groups with
a P-value<5% were considered as differentially ex-
pressed. Validation of microarrays was performed using
qRT–PCR with Taqman probes as described above.
Global microarray expression analysis of public data
Analysis was performed as previously described with some
modiﬁcations (13). Brieﬂy, CEL ﬁles were loaded into
ArrayAssist (Stratagene, La Jolla, CA, USA) and probes
were normalized using the GC-RMA algorithm. ANOVA
was performed on all groups using a Benjamini and
Hochberg FDR correction. Genes whose expression
differed by at least 2-fold between any two groups with
a P-value<5% were considered as differentially ex-
pressed. Validation of microarrays was performed using
qRT–PCR with Taqman probes as described above.
RESULTS
Global mapping of HDAC1 binding in ES and TS cells
To interrogate genome-wide promoter binding of the
HDAC1 in ES and TS cells, we used ChIP-chip analysis,
using an antibody speciﬁc to HDAC1. Chromatin was
prepared from ES and TS cells as previously described
(12,13). HDAC1 ChIP-enriched DNA sequences were
ampliﬁed and hybridized to high-density DNA promoter
tiling arrays encompassing regions of 28000 murine pro-
moters (‘Materials and Methods’ section). Genomic
binding peaks of HDAC1 in ES and TS cells were
analyzed using Tilemap (16) and annotated to the
nearest TSS using CisGenome (14) (Supplementary
Tables S1 and S2). HDAC1-bound regions are enriched
near the TSSs of target genes (Figure 1A). Only a small
number of HDAC1-bound regions were found within
proximal promoter regions [<300bp upstream or down-
stream of TSS; ES cells (51 genes), TS cells (103 genes)],
while the majority of bound regions occupied distal regu-
latory regions (>300bp-upstream or downstream from
TSS). To further evaluate binding patterns of genes
bound by HDAC1, we clustered the binding proﬁles of
HDAC1 using a 4-kb window around the enriched peak,
and found that the intensity and length of
HDAC1-binding proﬁles were similar between ES and
TS cells (Figure 1B). We identiﬁed 2315 genes bound by
HDAC1 in ES cells, 2538 genes bound by HDAC1 in TS
cells, and 1032 genes co-bound by HDAC1 in ES and TS
cells (Figure 1C).
Using Ingenuity Pathway Analysis (IPA) to functionally
annotate HDAC1 target genes, we found that HDAC1
target genes are located at a similar frequency in
subcellular locations including cytoplasm, extracellular
space, nucleus and plasma membrane, in ES and TS
cells (Figure 1D). For example, 33% of HDAC1 targets
in ES cells were located in the nucleus compared with 29%
in TS cells (Figure 1D). Moreover, IPA identiﬁed several
biological processes overrepresented in genes bound by
HDAC1 in ES and TS cells including gene expression
and cellular-, organismal-, embryonic- and tissue develop-
ment (Figure 1E and F). To further compare Gene
Ontology (GO) terms associated with genes bound by
HDAC1 in ES and TS cells, we evaluated pair-wise cor-
relations between GO terms associated with HDAC1
bound genes in ES and TS cells using AutoSOME (17),
and clustered these results using Spotﬁre. Hierarchical
clustering revealed the overrepresentation of related GO
terms associated with HDAC1 targets in ES and TS cells
including processes such as development and disease
(Figure 1E and F), implicating a role for HDAC1 in
regulating genes involved in common biological processes
in ES and TS cells. To functionally categorize genes bound
by HDAC1 in both ES and TS cells, we analyzed pair-wise
correlations between GO terms associated with HDAC1
targets in both ES and TS cells using AutoSOME. Next,
to identify clusters of GO terms represented in
HDAC1-occupied genes, we generated a network map
using Cytoscape (18) (Figure 1G). Using this approach,
we identiﬁed clusters of GO terms belonging to multiple
biological processes, which are overrepresented in genes
bound by HDAC1 in ES and TS cells, including develop-
ment (connective tissue, embryonic, nervous system, or-
ganismal and tissue) and disease (cancer, genetic
disorder, reproductive system and respiratory), suggesting
that many HDAC1 targets in ES and TS cells are func-
tionally related to one another.
Next, we validated a subset of HDAC1 targets in ES
cells by performing chromatin immunoprecipitation
followed by qPCR analysis (ChIP–PCR). In this
analysis, we conﬁrmed that HDAC1 binding was
enriched at active genes (Klf4, Oct4, Zfp42, etc.) and
inactive genes (Notch1, Tead4, etc.) in ES cells
(Figure 1H).
HDAC1 occupies core pluripotency-related genes in ES
cells and trophoblast-speciﬁc genes in TS cells
Our genome-wide promoter analysis revealed that
HDAC1 binds many genes in ES cells, which are import-
ant in maintaining pluripotency including the core tran-
scription factors Oct4, Sox2 and Nanog and other genes
whose expression is enriched in ES cells including Fgf4,
Mbd3, Rest, Sox2, Tbx3 and Zfp42 (Figure 2A;
Supplementary Table S1). Our results also show that
HDAC1 binds many genes in TS cells, which are expressed
in the TE and trophoblast lineage including Bmpr1a,
Cdkn1c, Cdx2, Elf5, Eomes, Ets2, Gata2/3, Hand1,
Msx2 and Tcfap2c (13) (Figure 2B and C;
Supplementary Table S2). Additionally, HDAC1-
occupied genes that are highly expressed in both ES and
TS cells including the de novo DNA methyltransferase
Dnmt3b, Eed, Jmjd3/4, Klf5, Lin28, Myc, Nr4a1/5a1,
Sox2 and Tbx3, demonstrating that HDAC1 occupies epi-
genetic regulators and genes involved in maintaining
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Figure 1. HDAC1 binding proﬁles and functional annotation of target gene in ES cells and TS Cells. (A) HDAC1 binding proﬁles near TSSs in ES
and TS cells. (B) HDAC1 binding proﬁles were centered on enrichment peaks [2, +2 kb] and clustered. (C) Venn diagram showing overlap of
HDAC1-bound genes in ES and TS cells. (D) GO functional annotation of HDAC1-bound genes in ES and TS cells was performed using IPA. GO
terms for cellular location were evaluated using IPA and represented as a percentage of total genes bound by HDAC1 in ES and TS cells. (E and F)
Hierarchical clustering heat map of pair-wise afﬁnities between any two GO terms associated with HDAC1-bound genes in (E) ES and (F) TS cells.
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(continued)Figure 1. Continued
IPA was used to functionally annotate HDAC1 bound genes. AutoSOME was used to generate pair-wise association values. (G) Network map
illustrating GO term analysis of HDAC1-occupied genes in both ES and TS cells. Nodes are colored by clusters of GO terms, where correlated terms
are grouped by color. Edges represent pair-wise afﬁnities between any two GO terms, as clustered by AutoSOME (0=GO terms never co-cluster;
1=GO terms always co-cluster). Cytoscape was used to generate the network using the edge-weighted spring embedded layout algorithm.
(H) Conﬁrmation of HDAC1 ChIP-chip enriched regions in ES cells using ChIP–PCR. Results are shown as percent enrichment relative to Input.
Figure 2. Genome-wide binding of HDAC1 and histone H3 acetylation (AcH3) demarcates ES and TS cells self-renewal. HDAC1 occupancy and
AcH3 at (A) pluripotency-related genes in ES cells (Pou5f1/Oct4, Nanog), (B) genes whose expression is enriched in the trophoblast lineage (Elf5,
Gata3) and (C) genes whose expression is enriched in ES and TS cells (Sox2, Tbx3). (D) HDAC1 occupancy and transcription factor (Oct4, Sox2 and
Nanog) binding, and histone marks (AcH3, H3K4me3 and H3K27me3) at core transcription factor loci in ES cells (Pou5f1, Sox2 and Nanog). MA
enrichment values (log2) are shown.
Nucleic Acids Research,2012, Vol.40, No. 7 2929self-renewal in both ES and TS cells (Figure 2C;
Supplementary Tables S1 and S2). These results are
surprising because HDAC1 has been traditionally shown
to localize with repressed or inactive genes.
Because HDAC1 was found to occupy promoters of
many pluripotency-related genes in ES cells, we were inter-
ested in comparing the HDAC1-binding proﬁles to those
of OCT4, SOX2 and NANOG and proﬁles of transcrip-
tionally active and inactive histone modiﬁcations, in ES
cells. Therefore, we compared HDAC1 binding proﬁles
with OCT4, SOX2 and NANOG binding (19) and
proﬁles of histone modiﬁcations including AcH3 (13),
H3K4me3 (19) and H3K27me3 (19), at the core
pluripotency-related genes Oct4, Sox2 and Nanog, in ES
cells (Figure 2D). It is known that OCT4, SOX2 and
NANOG co-bind their own promoters in ES cells
(20,21), and the promoter regions of Oct4, Sox2 and
Nanog are associated with the transcriptionally active
histone modiﬁcations AcH3 and H3K4me3. While our
results demonstrate that HDAC1 occupies Oct4, Sox2
and Nanog promoters in ES cells, HDAC1 binding
patterns are aligned more with the proﬁles of active
histone modiﬁcations (AcH3 and H3K4me3) compared
to the binding proﬁles of OCT4, SOX2 and NANOG
(19) (Figure 2D). These ﬁndings suggest that HDAC1
may regulate ES and TS cells self-renewal and chromatin
structure by binding chromatin regions with speciﬁc
histone modiﬁcations.
HDAC1 binding is associated with histone acetylation
(AcH3) and gene activity in ES and TS cells
ES cells uniquely express Oct4 and Nanog, while TS cells
uniquely express Cdx2 and Eomes, and ES and TS cells
both express high levels of Hdac1, Sox2 and Tbx3
(Figure 3A) (13,22). Although expression of Oct4 and
Cdx2 is uniquely expressed in ES and TS cells, respect-
ively, HDAC1 binding to Oct4 in ES cells and Cdx2 in TS
cells suggests a positive role for HDAC1 in supporting
transcription of key target genes in both cell types. To
further understand the expression state of HDAC1
targets in ES and TS cells, we used gene set enrichment
analysis (GSEA) (23) to compare HDAC1 target genes
with histone H3 acetylation (AcH3) marks in ES (15)
and TS cells (13), and public microarray expression
data from ES cells and differentiated embryoid bodies
(EBs) (24), undifferentiated and retinoic acid (RA)-
differentiated ES (22), ES and TS cells (25) and undiffer-
entiated and differentiated TS cells (13). These GSEA
results showed that the majority of HDAC1 target genes
are active in ES and TS cells. Notably, expression of
68% and 58% of the HDAC1 targets was enriched
more in ES cells compared with EBs (Figure 3B) and
(RA)-differentiated ES cells, respectively (Figure 3C).
Also, expression of 61% of the HDAC1 targets in ES
cells was elevated in ES cells compared with TS cells, and
expression of 74% of the HDAC1 targets in TS cells was
enriched in TS cells compared with ES cells (Figure 3D).
This analysis also revealed that HDAC1 proﬁles resemble
AcH3 proﬁles, demonstrating that HDAC1 binding
proﬁles are correlated with gene activity. Moreover,
expression of 73% of the HDAC1 targets was enriched
in undifferentiated TS cells compared with differentiated
TS cells (Figure 3E). Altogether, these ﬁndings demon-
strate that HDAC1 binds a higher proportion of active
genes in ES and TS cells, and suggests that the frequency
of binding is associated with retention of the pluripotent
state.
Next, we evaluated the expression state of functional
HDAC1 targets in ES and TS cells by ranking genes ac-
cording to their expression change following ES and TS
cells differentiation and evaluating the proportion of genes
bound by HDAC1 using a sliding window of 500 genes
(Figure 3F and G). We observed a greater proportion of
genes bound by HDAC1, which were downregulated upon
ES and TS cell differentiation compared with genes that
were upregulated (Figure 3F and G), suggesting that
HDAC1 binds mainly active genes in ES and TS cells.
While this approach is useful for understanding the ex-
pression state of HDAC1 targets in ES and TS cells
relative to their differentiated progeny, it does not
directly address the absolute expression of HDAC1
targets. Therefore, we ranked genes according to their
absolute expression in ES and TS cells, and then evaluated
the proportion of genes occupied by HDAC1 (Figure 3H
and I). Using this approach, we found that HDAC1 binds
more genes that are highly expressed in ES and TS cells
compared with genes that are expressed at a low level.
Overall, these ﬁndings suggest that HDAC1 occupies
genes that are active in ES and TS cells relative to
differentiated cells, and genes that are highly expressed
in ES and TS cells.
Previous studies demonstrated that Hdac1 knockout
mice die during development before E10.5 (3), and
Hdac1 null ES cells are only partially impaired in their
ability to proliferate and maintain self-renewal. It is
possible that the relatively normal phenotype of
HDAC1 knockout ES cells may be due to elevated expres-
sion levels of other HDAC proteins such as HDAC2 and
HDAC3 (3), which may have redundant functions in ES
cells. To address this possibility, we evaluated the global
expression of Hdac1-deﬁcient ES cells and wild-type ES
cells using public data (GEO accession number: GSE5583)
(5). We identiﬁed 673 genes, including 18% (126 genes) of
HDAC1 targets in ES cells identiﬁed in this study, which
were differentially expressed between Hdac1-deﬁcient ES
cells and wild-type ES cells (>1.5-fold, <0.67-fold,
FDR-corrected P-value<0.05). When considering only
genes with a P-value<0.05, we identiﬁed 1270 differen-
tially expressed genes, including 25% (322 genes) of
HDAC1 targets in ES cells. Within this data set, a
number of pluripotency-associated genes (e.g. Nanog,
Sox2, Tbx3, Fgf4 and Zfp42) were upregulated in
Hdac1-deﬁcient ES cells (Figure 4A and B), suggesting
that HDAC1 functional targets are active in ES cells.
However, to further understand the expression state of
HDAC1 targets in ES cells on a global scale, we used
GSEA to compare HDAC1 target genes from this study
with gene expression data from wild-type and Hdac1
knockout ES cells (5). The majority of genes bound by
HDAC1 in ES cells and differentially expressed between
wild-type and Hdac1 knockout ES cells (P=0.05, FC
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Figure 3. HDAC1 binding is positively correlated with histone acetylation (AcH3) and gene activity in ES and TS cells. (A) Comparison of global
gene expression patterns in ES and TS cells. Genes are colored according to their expression ratio in ES/TS cells. (B–E) GSEA analysis of HDAC1
bound genes and histone acetylation (AcH3) in (B) ES cells and EBs, (C) ES and RA-differentiated ES cells, (D) ES and TS cells and (E)
undifferentiated and differentiated TS cells. (F and G) Relationship between changes in gene expression following differentiation of (F) ES and
(G) TS cells and the proportion of genes bound by HDAC1, using a sliding scale of 500 genes. HDAC1-bound genes are mainly active in ES and TS
cells, as shown by the greater proportion of HDAC1-bound genes whose expression is downregulated following ES and TS cells differentiation
compared with genes whose expression is upregulated following differentiation. (H and I) Relationship between the absolute expression of genes in
(H) ES and (I) TS cells and the proportion of genes bound by HDAC1. Elevated gene expression in ES and TS cells is positively correlated with
HDAC1 binding.
Nucleic Acids Research,2012, Vol.40, No. 7 2931>1.5, <0.67) were upregulated in Hdac1 knockout ES
cells (Figure 4C and D), demonstrating that Hdac1
serves a predominantly repressive role in transcription.
However, by ranking genes according to their absolute
expression in ES cells, we observed a greater proportion
of differentially expressed genes in Hdac1 knockout ES
cells that were highly enriched in ES cells (Figure 4E),
suggesting that HDAC1 functional targets are highly ex-
pressed in ES cells. In addition, by ranking genes
according to their expression change following ES cell dif-
ferentiation, we observed a greater proportion of differen-
tially expressed genes in Hdac1 knockout ES cells, which
were downregulated upon ES cell differentiation (Figure
4F), further demonstrating that HDAC1 binds mainly
active genes in ES cells.
Moreover, several HDACs, including those belonging
to Classes I (Hdac2) and II (Hdac6), were upregulated
in Hdac1-deﬁcient ES cells (Figure 4G). Additional
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Figure 4. Hdac1 regulates expression of pluripotency genes in ES cells. (A and B) Global expression analysis of control and Hdac1 knockout (KO)
ES cells. (A) Hierarchical clustering and scatter plot of genes with a (A) P-value<0.05 (fold change in parentheses) and (B) a fold change >1.5 or
<0.67. (C and D) GSEA analysis of HDAC1-bound genes in control and Hdac1 KO ES cells. (E and F) Relationship between (E) the absolute
expression of genes in ES cells and (F) changes in gene expression following differentiation of ES cells and the proportion of genes differentially
expressed in Hdac1 KO ES cells, using a sliding scale of 500 genes. (G) Log-adjusted mean intensity and fold-change expression levels of Hdac1,
Hdac2 and Hdac6 in wild-type and Hdac1 KO ES cells.
2932 Nucleic Acids Research, 2012,Vol.40, No. 7HDACs represented in this data set (Hdac3, Hdac5 and
Hdac7) were not expressed at signiﬁcant levels.
Interestingly, while the sum of the expression levels of
Hdac2 and Hdac6 was similar to the expression level of
Hdac1 in wild-type ES cells, the cumulative expression
of Hdac2 and Hdac6 was upregulated 155% in
HDAC1-deﬁcient ES cells, suggesting that Hdac2 and
Hdac6 may partially compensate for the loss of Hdac1
(Figure 4G). While extensive knockdown or knockout
studies of multiple HDACs would address the potentially
redundant roles of HDACs in ES cell self-renewal, an al-
ternative to these technically challenging methods involves
inhibiting Classes I and II HDACs using TSA.
Therefore, to better understand the positive or negative
control of HDAC1 versus other HDAC target genes in ES
and TS cells, we compared HDAC1 targets identiﬁed in
our study with global mRNA expression data from ES
and TS cells treated with the HDAC inhibitor, TSA.
Total RNA was harvested from ES and TS cells treated
with 10, 50 and 100nM TSA for 24h, and transcriptome
analysis was performed using Affymetrix Mouse 430 v2.0
microarrays. Genes whose expression differed by at least
2-fold between any two groups with an FDR-adjusted
P-value<0.05 were considered differentially expressed.
Treatment of ES cells with TSA for 24h resulted in
downregulation of pluripotency-related genes including
Oct4, Esrrb, Nanog, Rest, Zfp42 and Utf1 and
upregulation of lineage speciﬁc genes including Cdx2,
Cebpa, Fgfr2, Gata3 and Mmp9. Moreover, we
observed a loss of normal ES cell colony morphology
upon treatment with TSA (Figure 5A). These results are
in agreement with results from previous studies, which
showed that HDAC inhibition leads to downregulation
of pluripotency genes (5,26). Treatment of TS cells with
TSA for 24h resulted in downregulation of TS cell-speciﬁc
genes including Bmpr1a, Elf5, Eomes, Gata3, Lin28 and
Tead4 and upregulation of trophoblast-speciﬁc genes
including Cdx1, Cebpa and Kitl. Also, we observed a
loss of normal TS cell colony morphology, where
TSA-treated TS cells lost their tight cell–cell contact,
which is indicative of differentiation (Figure 5B).
A more detailed analysis of this whole-genome mRNA
expression data using HCA, k-means clustering analysis
and principal component analysis (PCA) indicated that
pluripotency-related genes are downregulated following
inhibition of HDACs in ES cells (Figure 5C), and
trophoblast-speciﬁc genes are downregulated following in-
hibition of HDACs in TS cells (Figure 5D). Moreover,
PCA analysis revealed that ES and TS cells treated with
increasing concentrations of TSA (10, 50 and 100nM)
move through the ﬁrst two components along the PC1
axis (Figure 5C and D). qRT–PCR was used to conﬁrm
our microarray results. Genes whose expression is highly
enriched in ES cells including Dppa5, Esrrb, Pou5f1, Rest,
Rex1/Zfp42 and Utf1 were downregulated, while
lineage-speciﬁc genes including Cdx2, Cebpa, Csh2/
Prl3b1, Fgfr2, Gata3, Hand1, Mmp9 and Tbx5 were
upregulated following treatment with TSA (Figure 5E).
To strengthen the observed link between HDAC
binding and gene expression of ES and TS cells in the
presence or absence of TSA, we ranked genes according
to their expression change following TSA treatment, or
absolute expression in ES or TS cells and then evaluated
the proportion of genes bound by HDAC1 (Figure 5F
and G). The number of genes downregulated following
TSA treatment of ES and TS cells was greater than the
number of genes upregulated in the population of genes
bound by HDAC1. Moreover, HDAC1 binds more genes
that are highly expressed in ES or TS cells compared with
genes that are expressed at a low level (Figure 5F and G).
These ﬁndings are unexpected because HDAC1 binding
and subsequent gene expression occur more frequently
at active versus inactive genes in ES cells.
The NuRD component MBD3 occupies a subset of
HDAC1 targets in ES cells
The NuRD complex is one of the several complexes with
which HDAC1 is associated. MBD3, along with HDAC1,
is a core component of the NuRD complex, which is es-
sential for embryogenesis and ES cell pluripotency (27).
However, targets of MBD3 have not been investigated in
ES cells. Therefore, to identify global promoter binding of
MBD3 in ES cells, we used ChIP-chip analysis using an
antibody speciﬁc to MBD3. Chromatin and MBD3
ChIP-enriched DNA was prepared as described above.
MBD3 ChIP-chip data was analyzed using CisGenome
(Supplementary Table S3). To compare the binding
patterns of genes occupied by MBD3 and HDAC1, we
clustered MBD3 binding proﬁles using a 4-kb window
around the enriched peak, and found that HDAC1- and
MBD3-binding proﬁles are similar in intensity and length
(Figure 6A). We identiﬁed 1052 genes bound by MBD3 in
ES cells, and 311 genes co-bound by MBD3 and HDAC1
(Figure 6B; Supplementary Table S3). Several genes that
were co-bound by MBD3 and HDAC1 include
pluripotency regulators such as Oct4, Nanog and Klf4
(Figure 6C).
Next, to understand the expression state of MBD3
targets in ES cells, we used GSEA to compare MBD3
targets with microarray expression data from ES cells
and EBs (24). Our results show that MBD3 targets are
expressed in both ES cells and EBs (Figure 6D). We
further evaluated the relationship between MBD3 and
HDAC1 binding and expression in ES cells and EBs by
generating a terrain map of MBD3 and HDAC1 target
gene expression values using gCLUTO (Figure 6E). This
result shows that HDAC1 binds mainly active genes, while
MBD3 binds both active and inactive genes. While these
analyses are useful in understanding the expression state
of MBD3 targets in ES cells, it does not address the
absolute expression of MBD3 targets. Therefore, we
ranked genes according to their absolute expression in
ES cells, and then evaluated the proportion of genes
occupied by MBD3 (Figure 6F). Using this method, we
observed that MBD3 binds more genes that are highly
expressed in ES cells compared with genes that are ex-
pressed at a low level. However, MBD3 does not bind
as frequently to active genes compared to HDAC1.
Altogether, these results suggest that MBD3 occupies
active and inactive genes, including a subset of
HDAC1-occupied genes and pluripotency regulators.
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Figure 5. Global expression analysis of TSA treated ES and TS cells. (A) ES and (B) TS cells cultured in the presence of 10, 50 and 100nM TSA for
24h. Normal colony morphology was lost in ES and TS cells cultured with TSA. HCA of differentially expressed genes (>2-fold; upregulated genes
are red, downregulated genes are green) in (C) ES and (D) TS cells following treatment of TSA (10, 50 and 100nM) for 24h. PCA plots show
differentially expressed genes clustered according to k-means. K-means clustered groups are shown in another plot (six groups of genes). The lower
PCA plots of the ﬁrst two components describe most of the data variability between the samples. (E) qRT–PCR expression analysis of ES cells
treated with TSA for 24h. (F and G) Relationship between changes in gene expression following TSA treatment, or absolute expression of these
genes, and the proportion of genes bound by HDAC1 in ES and TS cells, using a sliding window of 500 genes. There is a greater proportion of
HDAC1 bound genes whose expression is downregulated following TSA treatment compared with genes whose expression is upregulated upon TSA
treatment, suggesting that HDAC1 binds to mainly active genes in ES and TS cells.
2934 Nucleic Acids Research, 2012,Vol.40, No. 7Functional analysis of HDAC1 targets
Recent genome-wide RNAi studies have provided signiﬁ-
cant insight into the genetic basis for ES cell pluripotency
(28,29). Results from these studies describe genes that are
positive regulators of Oct4 expression and ES cell
pluripotency. To investigate the function of HDAC1
targets in ES cells, we evaluated the overlap between
HDAC1 targets in ES cells identiﬁed in our study and
genes identiﬁed in two previous RNAi screens. Next, we
ranked genes according to their expression change follow-
ing differentiation and evaluated the proportion of genes
bound by HDAC1 (Figure 7A and B). Genes whose ex-
pression was downregulated following differentiation, also
bound by HDAC1, include positive regulators of Oct4
expression such as Oct4, Sox2, Dnmt3l, Nanog, Lin28,
FoxD3, Klf4 and Zfp42 (Figure 7A and B), demonstrating
that HDAC1 occupies pluripotency regulators that
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Figure 6. Global promoter occupancy of the NuRD component MBD3 in ES cells. (A) MBD3 binding proﬁles were centered on enrichment peaks
[2, +2 kb] and clustered. (B) Venn diagram showing overlap of MBD3 and HDAC1 bound genes in ES cells. (C) Co-occupancy of MBD3 and
HDAC1 at pluripotency-related genes in ES cells (Pou5f1/Oct4, Nanog and Klf4). (D) GSEA analysis of MBD3-bound genes in ES cells and EBs.
(E) 3D terrain map of MBD3 and HDAC1 target gene expression in ES cells and EBs. More HDAC1 targets are expressed in ES cells relative to
EBs, while MBD3 targets are expressed in both ES cells and EBs. Peak height is proportional to the internal similarity of clusters and peak volume is
proportional to the number of features within the cluster. (F) Relationship between the absolute expression of genes in ES cells and the proportion of
genes bound by MBD3. Elevated gene expression is slightly correlated with MBD3 binding.
Nucleic Acids Research,2012, Vol.40, No. 7 2935support self-renewal of ES cells. These results demonstrate
that a subset of HDAC1 target genes is important for ES
cell pluripotency and Oct4 expression.
Genome-wide mRNA proﬁles have been recently
compared between many human cell populations (30).
These results describe regulatory networks that deﬁne
distinct cell types, including ES cells and adult stem cells
such as neural stem and progenitor cells. To understand
the expression of HDAC1 target genes in an assortment of
cell lines, we compared ES and TS cells HDAC1 targets
with gene expression data from human cells (30). Then, we
evaluated pair-wise associations between cell types using
AutoSOME, and clustered these results in a landscape
plot (Figure 7C). Our results show that cells are clustered
according to their unique expression proﬁle of HDAC1
target genes, demonstrating that the expression of
HDAC1 targets demarcates human cell lines into func-
tional groups of stem cell populations with varying poten-
tial. For example, expression of ES and TS cell HDAC1
targets in various human ES cell lines is more similar to
one another compared to the expression of these genes in
neural progenitors or smooth muscle cells (Figure 7C).
These results were conﬁrmed by PCA analysis of ES and
TS cells HDAC1 target gene expression in human cell
types. PCA showed that cell types with similar potential
and level of HDAC1 expression are clustered together
(Figure 7D). In conclusion, by investigating the expression
of ES and TS cells HDAC1 targets in many cell types,
these results offer valuable functional insight into tran-
scriptional networks of ES and TS cells.
DISCUSSION
Our genome-wide evaluation of HDAC1 occupancy in ES
and TS cells lends new insight into epigenetic mechanisms
that support self-renewal in pluripotent ES and
multipotent TS cells. By mapping HDAC1 binding in
ES and TS cells and the NuRD component MBD3 in
ES cells on a global scale, and evaluating global mRNA
expression of wild-type and Hdac1 knockout ES and ES
and TS cells cultured in the presence of the HDAC inhibi-
tor, TSA, we found that HDAC1 distributions are present
to a larger extent at active genes compared with inactive
genes. We also observed upregulation of pluripotency-
related genes in Hdac1 knockout ES cells relative to
wild-type ES cells, suggesting that Hdac1 may limit the
expression level of highly enriched genes in ES cells.
Results presented here also show that in ES cells,
HDAC1 binds key genes implicit in maintaining ES cell
self-renewal such as Oct4, Sox2 and Nanog and in TS
cells, HDAC1 binds important trophoblast-lineage genes
such as Cdx2, Elf5 and Eomes. Our results also show that
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Figure 7. Functional analysis of HDAC1 targets. (A and B) Relationship between changes in gene expression differentiation of ES cells and the
proportion of genes bound by HDAC1, also identiﬁed as positive regulators of Oct4 expression in genome-wide RNAi screens, using a sliding scale
of 500 genes. HDAC1 bound genes that are highly expressed in ES cells, and positive regulators of Oct4 expression), include pluripotency genes such
as Oct4, Sox2, Nanog, Lin28, FoxD3, Klf4 and Dnmt3l. (C) Hierarchical clustering landscape plot of pair-wise afﬁnities between expression values of
any two human cell lines associated with HDAC1 bound genes in ES and TS cells. AutoSOME was used to generate pair-wise association values.
Cell types are clustered according to their expression of HDAC1 target genes in ES and TS cells. (D) PCA analysis of HDAC1 target gene expression
in a set of human cell lines.
2936 Nucleic Acids Research, 2012,Vol.40, No. 7MBD3 and HDAC1 co-occupy several pluripotency regu-
lators including Oct4, Nanog and Klf4. Moreover, a
subset of HDAC1-occupied genes are overexpressed in
both ES and TS cells such as Sox2 and Tbx3. Therefore,
by identifying global HDAC1 binding sites in ES and TS
cells, our work provides clues about epigenetic phenom-
ena that may contribute to mechanisms of ES and TS cells
self-renewal.
ES and TS cells, which are derived from
preimplantation embryos, share the capacity to self-renew
indeﬁnitely in vitro in the presence of appropriate external
signals including LIF and FGF4, respectively. During
preimplantation blastocyst development, LIF produced
by trophectodermal (TE) cells promotes ICM cell self-
renewal and pluripotency, while FGF4 produced by
ICM cells aids in TE cell proliferation and self-renewal.
This paracrine signaling mechanism suggests a coopera-
tive relationship between pluripotent ICM and
multipotent cells of the TE, which persists upon formation
of the blastocyst. Our results implicate a role for HDAC1
in propagating these signals, where HDAC1 was found to
bind promoter regions of genes encoding components of
the LIF and FGF4 signaling pathways in ES and TS cells.
We observed HDAC1 binding to LIFR and FGF4 in ES
cells, and HDAC1 binding to FGFR2 in TS cells
(Supplementary Tables S1 and S2), demonstrating that
HDAC1 occupies extracellular genes including growth
factors and cytokines (LIF, FGF4), and receptors
(FGFR2), which are critical for maintaining ES and TS
cells self-renewal. These results suggest that HDAC1 oc-
cupancy of target genes in ES and TS cells may serve to
reinforce signaling cascades that participate in the regula-
tion of self-renewal.
The ability of ES cells to differentiate into cells of the
three germ layers, and TS cells to differentiate into cells of
the trophoblast lineage is determined in part by their dis-
tinctive epigenetic programs, where epigenetic modiﬁers
and transcription factors participate in regulating chroma-
tin structure by modifying histones or recruiting histone
modiﬁers. For example, trithorax and Polycomb group
proteins (PcGs) regulate regions of histone modiﬁcations
H3K4me3 and H3K27me3, respectively, which are
associated with developmentally repressed genes in ES
cells that are primed for activation upon differentiation
(31–33). Additional studies have demonstrated that chro-
matin remodeling proteins such as BRG1 are important in
regulating ES (12,34) and TS cells self-renewal (13), and
BRG1 was found to associate with genes involved in ES
and TS cells self-renewal. We observed co-binding of
HDAC1 and BRG1 at a number of target genes in ES
and TS cells (data not shown), suggesting that multiple
epigenetic regulators may co-regulate transcription of
target genes. These results are in agreement with
previous ﬁndings, which demonstrated that BRG1 cooper-
ates with HDAC to regulate target gene expression (35).
Moreover, transcription factors including OCT4 and
NANOG have been shown to associate with epigenetic
regulators including HDAC1 (36). In this study, we
observed co-occupancy of HDAC1 and OCT4, SOX2
and NANOG (37) at 347 target genes in ES cells, and
co-occupancy of HDAC1 and BRG1, EOMES and
TCFAP2C (13) at 295 genes in TS cells, suggesting that
co-binding of transcription factors and epigenetic modi-
ﬁers at target genes may be important in maintaining ES
and TS cells self-renewal.
HDACs are generally thought to act as transcriptional
repressors, by removing acetyl groups at inactive genes.
HDAC1 has been shown to function as a co-repressor in
multiprotein complexes, after being recruited to DNA by
proteins in complexes such as the NuRD, the SIN3
corepressor, the CoREST, the Nanog- and Oct4-
associated deacetylase (NODE) and the SHIP1 complexes
(38). In addition, HDAC1 has been shown to be recruited
by additional complexes such as the Polycomb repressive
complex 2, which catalyze histone H3 K27 trimethylation
at PcG target genes (39). Because several of these tran-
scriptionally repressive HDAC1-containing complexes,
such as NuRD, NODE and PcG, have important roles
in normal ES cell function (27,31,36), it is plausible that
HDAC1 associates with predominantly inactive genes in
ES cells. An alternative interpretation has been suggested
from results in T cells where HDACs have been recently
shown to bind mainly to active genes but exert regulatory
functions on active and inactive genes (11). These results
are unexpected because HDACs are well known for their
transcriptionally repressive functions. While these ﬁndings
may seem to suggest a paradigm shift for understanding
HDAC function in somatic cells, the authors conclude
that HDACs may be more prevalent at active genes
compared with inactive genes to reset the acetylation
state, whereas inactive genes may not require continuous
binding of HDACs to maintain their inactive state or
condensed chromatin structure (11).
Because HDACs have a repressive role, it is reasonable
to assume that inhibition of HDACs would positively in-
ﬂuence the expression state of HDAC target genes.
Indeed, we observed upregulation of pluripotency genes
in Hdac1 knockout ES cells relative to control ES cells.
However, we found that treatment of ES cells with the
general HDAC inhibitor TSA resulted in downregulation
of pluripotency-related genes and upregulation of
lineage-speciﬁc genes, which is similar to previous results
(26), demonstrating that HDACs as a whole positively
and negatively regulate expression of target genes. It has
been also demonstrated that treatment with TSA increases
chromatin accessibility by increasing acetylation levels
(40). HDAC inhibitors have been also used to inﬂuence
chromatin accessibility during reprogramming. Recent
work has demonstrated that four transcription factors
including OCT4, SOX2, KLF4 and MYC are sufﬁcient
to induce reprogramming of somatic cells to a pluripotent
state (41). While the reprogramming process is relatively
inefﬁcient, treatment with HDAC inhibitors such as TSA,
VPA and SAHA signiﬁcantly enhances the rate of
generating iPS cells (9,10). Our results show that
HDAC1 binds the four reprogramming factors Oct4,
Sox2, Klf4 and c-Myc in ES cells (Supplementary Table
S1). Therefore, treatment of HDAC inhibitors during the
reprogramming process may allow Oct4, Sox2, Klf4 and
c-Myc to more efﬁciently activate or repress target genes
by regulating chromatin accessibility and relaxing repres-
sive chromatin regions.
Nucleic Acids Research,2012, Vol.40, No. 7 2937HDACs are also thought to regulate cell cycle
progression, where HDAC1 null ES cells have reduced
proliferation rates and increased expression of the
cyclin-dependent kinase inhibitor, p21 (also known as
Cdkn1a) (3). Our results support a role for HDAC1 in
regulating proliferation and cell cycle progression, where
HDAC1 was found to bind cell cycle regulators such as
cyclin-dependent kinase inhibitors (Cdkn1a/b), cyclin de-
pendent kinases (Cdk4, 6), cyclin genes (Ccnd1/2,
Ccne1/2, etc.) and Myc (Supplementary Tables S1 and
S2), in ES and TS cells. We also observed HDAC1
binding to p53 (also known as Trp53), which induces
p21, and Mdm2, another member of the p53 tumor sup-
pressor family. p53 also plays a role in repressing Nanog
expression during ES cell differentiation (42), and p53 is
negatively correlated with reprogramming efﬁciency
(43,44). By associating with DNA regions encoding cell
cycle regulators and tumor suppressors, HDAC1 may
regulate the tumorigenic growth properties of ES and TS
cells.
In conclusion, results presented here describe a role for
HDAC1 in occupying active and inactive genes, including
key transcription factors that regulate ES and TS cells
self-renewal and differentiation. Consistent with our
ﬁndings, a recent study also demonstrated that HDACs
associated with active and inactive genes, albeit in a dif-
ferent cell context (11). Through genome-wide identiﬁca-
tion of HDAC1 binding sites in ES and TS cells, which
comprise the ﬁrst two stem cells populations to form
during development, our results describe epigenetic mech-
anisms of self-renewal and increase our understanding of
pluripotency and multipotency.
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